LCM
CLPT icon

Lucas Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Lucas Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$266K Buy
+16,730
New +$150K 0.31% 43

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lucas Capital Management's CLPT Position: Q4 2020 in Review

Lucas Capital Management opened a new position in ClearPoint Neuro (CLPT) in Q4 2020: 16,730 shares worth $266K. The stake represents 0.31% of the portfolio and ranks #43 among its holdings.

39 funds tracked by Wall St. Rank hold CLPT as of Q4 2020.

  • Lucas Capital Management held 16,730 shares of ClearPoint Neuro worth $266K as of Q4 2020.
  • ClearPoint Neuro was a new Lucas Capital Management position in Q4 2020.
  • ClearPoint Neuro made up 0.31% of Lucas Capital Management's portfolio in Q4 2020, its #43 holding.
  • 39 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2020.

Based on Lucas Capital Management's 13F filing for Q4 2020, filed 27 Jan 2021.